Cited by 71Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsCancer-related cognitive impairment studies

Type II diabetes in mild cognitive impairment and Alzheimer’s disease: Results from a prospective population-based study in Germany

Toro, Pablo, Schönknecht, Peter, Schröder, Johannes·2009·Journal of Alzheimer s Disease

Abstract

Diabetes mellitus type 2 (T2DM) is considered to be an important risk factor for mild cognitive impairment (MCI) and subsequent Alzheimer's disease (AD). The majority of studies relating T2DM to MCI and AD were performed in North America. We investigated the potential impact of T2DM on the development of MCI and AD in the Interdisciplinary Longitudinal Study on Adult Development and Aging which involves a representative birth cohort of subjects born between 1930 and 1932 in Germany. Subjects received a thorough psycho-geriatric examination and neuropsychological testing; particular care was taken to exclude subjects with severe medical or neurological conditions sufficient to explain the cognitive deficits, or other major psychiatric disorders. When compared to healthy subjects (n=159), patients with MCI (n=108) or AD (n=26) showed a tendency towards increased prevalence rates for T2DM (17% vs. 23%; chi2=1.7, p=0.18). In both patients with MCI and controls, T2DM was associated with psychomotor slowing but not deficits in other cognitive domains typically involved in MCI. Our findings indicate that T2DM is involved in MCI and may aggravate the clinical picture as a concomitant factor.

Integrity signals

Registry

Crossref · 10.3233/jad-2009-0981

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Type 2 diabetes patients have an elevated risk for Alzheimer's disease and manifest deficient CNS insulin signaling, likely because of decreased insulin uptake into the brain following sustained peripheral hyperinsulinemia.

    “an elevated risk for AD also exists in type 2 diabetes patients, who manifest deficient CNS insulin signaling (Matsuzaki et al., 2010; Ott et al., 1999; Toro et al., 2009; Watson and Craft, 2003), likely as a consequence of decreased insulin uptake into the brain following sustained peripheral hyperinsulinemia (Gerozissis et al., 1993; Kaiyala et al., 2000; Schwartz et al., 1990).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Toro, P., Schönknecht, P., & Schröder, J.
Affiliations
Heidelberg University (DE)
Corresponding author
Schröder, Johannes
Venue
Journal of Alzheimer s Disease
Published
2009-04-17
Volume
16
Issue
4
Pages
687-691
ISSN
  • 1387-2877 (ISSN-L)
  • 1875-8908
OpenAlex
W2113814333
Cited by
71
References
14
Citations by year
2025: 3 · 2024: 2 · 2022: 2 · 2021: 3 · 2020: 8 · 2018: 3 · 2017: 6 · 2016: 5 · 2015: 6 · 2014: 6 · 2013: 9 · 2012: 4
FWCI
3.51
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Alzheimer s Disease (publishedVersion)
  • PubMed (publishedVersion)
Funders
Pfizer
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cancer-related cognitive impairment studies
Keywords
type 2 diabetes, mild cognitive impairment
MeSH terms
Aged, Alzheimer Disease, Cognition Disorders, Diabetes Mellitus, Type 2, Female, Germany, Humans, Longitudinal Studies, Male, Mental Status Schedule, Neuropsychological Tests, Risk Factors, Multivariate Analysis, Community Health Planning

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review